Dr. Eugene Pietzak

Dr. Eugene Pietzak, MD, is a board-certified urologic surgeon specializing in the surgical treatment of bladder cancer, prostate cancer, upper urothelial cancer, and other cancers of the genitourinary system. He practices at Memorial Sloan Kettering Cancer Center, seeing patients at the Sidney Kimmel Center for Prostate and Urologic Cancers in Manhattan and MSK Commack on Long Island. Dr. Pietzak brings expertise across a wide array of surgical techniques, including minimally invasive and robotic approaches, with a strong commitment to achieving cures while preserving quality of life through careful surgical planning and meticulous technique. For men with prostate cancer requiring treatment, he primarily performs robotic-assisted radical prostatectomy, and for patients with bladder cancer requiring bladder removal, he offers advanced urinary reconstructive techniques such as continent neobladder diversion, which can re-create the natural urination pathway following surgery. Wherever possible, he employs nerve-sparing and function-sparing methods to help maintain urinary and sexual function.

Recognizing the complexity of genitourinary cancer treatment, Dr. Pietzak works closely with colleagues in medical oncology, radiation oncology, radiology, and pathology to individualize each patient's treatment plan based on their unique circumstances. He is deeply committed to a patient-centered approach that takes individual preferences into account, working with patients and their families to ensure they have thorough information about all available options before making critical decisions. Beyond his clinical practice, he is a surgeon-scientist engaged in clinical trials and translational research aimed at developing new treatments for bladder cancer, prostate cancer, and upper tract urothelial cancer. His research program is focused on identifying ways to personalize and improve treatment options, with particular emphasis on bladder cancer.

His research efforts have led to the development of several clinical trials at MSK, giving patients access to cutting-edge therapies before they become broadly available. These trials reflect his broader goal of providing patients with a better chance of cure and improved quality of life compared to currently available standard therapies. Through the integration of surgical expertise, translational science, and compassionate patient care, Dr. Pietzak continues to advance the field of urologic oncology and expand treatment possibilities for patients facing genitourinary cancers.